Hyperinsulinemia in newly diagnosed patients with multiple sclerosis (Q41160041)

27 September 2017

Hyperinsulinemia in newly diagnosed patients with multiple sclerosis (English)

1 reference

27 September 2017

Adela Penesova

1

1 reference

27 September 2017

Miroslav Vlcek

2

1 reference

27 September 2017

Richard Imrich

3

1 reference

27 September 2017

Lucia Vernerova

4

1 reference

27 September 2017

Andrea Marko

5

1 reference

27 September 2017

Milada Meskova

6

1 reference

27 September 2017

Lucia Grunnerova

7

1 reference

27 September 2017

Peter Turcani

8

1 reference

27 September 2017

Daniela Jezova

9

1 reference

27 September 2017

Branislav Kollar

10

1 reference

27 September 2017

language of work or name

1 reference

27 March 2015

1 reference

27 September 2017

Metabolic Brain Disease

1 reference

27 September 2017

30

1 reference

27 September 2017

4

1 reference

27 September 2017

895-901

1 reference

https://scigraph.springernature.com/pub.10.1007/s11011-015-9665-1

27 September 2017

0 references

cites work

Serum lactate as a novel potential biomarker in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Physical inactivity as the culprit of metabolic inflexibility: evidence from bed-rest studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Pharmacology, physiology, and mechanisms of incretin hormone action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Insulin release and peripheral sensitivity at the oral glucose tolerance test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Prolonged plasma half-life of insulin in patients with a genetic defect of high affinity binding sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Interleukin-6 and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Validity and reliability of self-reported total energy expenditure using a novel instrument.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

IGF-1 stimulates de novo fatty acid biosynthesis by Schwann cells during myelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Dysregulation of the autonomic nervous system predicts the development of the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Is metabolic flexibility altered in multiple sclerosis patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Muscle-derived interleukin-6--a possible link between skeletal muscle, adipose tissue, liver, and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Acute methylprednisolone administration induces a transient alteration of glucose tolerance and pyruvate dehydrogenase in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

The role of norepinephrine and insulin resistance in an early stage of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Use and abuse of HOMA modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-015-9665-1

Effects of physical activity, body mass index, waist-to-hip ratio and waist circumference on total mortality risk in the Swedish National March Cohort

21 January 2018

1 reference

12 December 2020

Elevated cerebrospinal fluid adiponectin and adipsin levels in patients with multiple sclerosis: a Finnish co-twin study

1 reference

12 December 2020

Targeting PPAR as a therapy to treat multiple sclerosis

1 reference

12 December 2020

A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic

1 reference

12 December 2020

Invivo insulin deficiency as a potential etiology for demyelinating disease

1 reference

12 December 2020

Evaluation of the relationship between leptin, resistin, adiponectin and natural regulatory T cells in relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Autonomic dysfunction in multiple sclerosis

1 reference

12 December 2020

Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease.

1 reference

12 December 2020

Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoassay

1 reference

12 December 2020

Prevalence of diabetes in patients with multiple sclerosis

1 reference

12 December 2020

Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress

1 reference

12 December 2020

10.1007/S11011-015-9665-1

Identifiers

DOI

1 reference

Dimensions Publication ID

27 September 2017

0 references

1 reference